« Back to Record
Michiels, S., Pugliano, L., Marguet, S., Grun, D., Barinoff, J., Cameron, D., Cobleigh, M., Di Leo, A., Johnston, S. R. D. S., Gasparini, G., Kaufman, B., Marty, M., Nekljudova, V., Paluch-Shimon, S., Pénault-Llorca, F., Slamon, D., Vogel, C., Von Minckwitz, G., Buyse, M., & Piccart-Gebhart, M. (2016). Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer. Annals of oncology, 27(6), mdw132, 1029-1034. doi:10.1093/annonc/mdw132
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/237863



